Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
BACKGROUND: Currently, population pharmacokinetic (PK) studies of anti-malarial drugs are designed primarily by the logistical and ethical constraints of taking blood samples from patients, and the statistical models that are fitted to the data are not formally considered. This could lead to impreci...
Main Authors: | Jamsen, K, Duffull, S, Tarning, J, Lindegardh, N, White, N, Simpson, J |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
BioMed Central
2011
|
פריטים דומים
-
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
מאת: Lindegardh Niklas, et al.
יצא לאור: (2011-07-01) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria.
מאת: Jamsen, K, et al.
יצא לאור: (2012) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
מאת: Jamsen Kris M, et al.
יצא לאור: (2012-07-01) -
Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
מאת: Tarning, J, et al.
יצא לאור: (2012) -
Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
מאת: Tarning, J, et al.
יצא לאור: (2012)